Medicated Skin Care in Finland
Euromonitor International's Medicated Skin Care in Finland market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 42 | Publication date: Oct 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
OTC HEALTHCARE IN FINLAND : MARKET INSIGHT
EXECUTIVE SUMMARY
Small value growth in 2006 in a mature and well-developed OTC market
Smoking cessation most dynamic due to lifestyle changes
Interest in preventative medicine pushes sales in mature VDS sector
Mature market, but room for continued growth
KEY TRENDS AND DEVELOPMENTS
Peak cycle for Finland’s economy may soon be over
Demographic trends point to growing OTC consumption
Obesity, a growing problem in Finland
Table 1 Number of Overweight Boys (%)
Table 2 Number of Overweight Girls (%)
Product Diversification Key in Mature Market
Growing Self-medication Trend
APPENDIX
OTC Registration and Classification
Summary 1 OTC Healthcare Switches 2005-2006
Vitamins & Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 3 Consumer Expenditure on Health Goods and Medical Services 2001-2006
MARKET INDICATORS
Table 4 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 5 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 6 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 7 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 8 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 9 Penetration of Private Label by Sector 2002-2006
Table 10 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 11 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 12 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 13 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
DEFINITIONS
Sources
Summary 2 Research Sources
LOCAL COMPANY PROFILES - FINLAND
FERROSAN AB OY - OTC HEALTHCARE - FINLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Ferrosan Ab Oy: Key Facts
Summary 4 Ferrosan Ab Oy: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 5 Ferrosan Ab Oy: Production Statistics
COMPETITIVE POSITIONING
Summary 6 Ferrosan Ab Oy: Competitive Position 2006
ORION GROUP - OTC HEALTHCARE - FINLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Orion Group: Key Facts
Summary 8 Orion Group: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Orion Oyj: Competitive Position 2006
OY LEIRAS FINLAND AB - OTC HEALTHCARE - FINLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Oy Leiras Finland Ab: Key Facts
Summary 11 Oy Leiras Finland Ab: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 12 Oy Leiras Finland Ab: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 13 Oy Leiras Finland Ab: Competitive Position 2006
RATIOPHARM OY - OTC HEALTHCARE - FINLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Ratiopharm Oy: Key Facts
Summary 15 Ratiopharm Oy: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 16 Ratiopharm Oy: Competitive Position 2006
VITABALANS OY - OTC HEALTHCARE - FINLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 17 Vitabalans Oy: Key Facts
Summary 18 Vitabalans Oy: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 19 Vitabalans Oy: Production Statistics
COMPETITIVE POSITIONING
Summary 20 Vitabalans Oy: Competitive Position 2006
MEDICATED SKIN CARE IN FINLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 14 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 15 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 16 Herbal vs Standard Medicated Skin Care 2001/2006
Table 17 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 18 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 19 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 20 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 21 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 22 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011